about
Modeling of a human circadian mutation yields insights into clock regulation by PER2Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesiaDual roles of FBXL3 in the mammalian circadian feedback loops are important for period determination and robustness of the clockRole of KIFC3 motor protein in Golgi positioning and integrationFunctional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.Interaction of MAGED1 with nuclear receptors affects circadian clock functionA Cryptochrome 2 mutation yields advanced sleep phase in humansAn intensity ratio of interlocking loops determines circadian period length.The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesisLDL Receptor-Related Protein 6 Modulates Ret Proto-Oncogene Signaling in Renal Development and Cystic Dysplasia.Loss of ZBTB20 impairs circadian output and leads to unimodal behavioral rhythmsFocused screening of mitochondrial metabolism reveals a crucial role for a tumor suppressor Hbp1 in ovarian reserve.A NANOS3 mutation linked to protein degradation causes premature ovarian insufficiency.Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFIIMAGED1: molecular insights and clinical implications.Inactivation of Cipc alters the expression of Per1 but not circadian rhythms in mice.The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.Haploinsufficiency of hnRNP U Changes Activity Pattern and Metabolic Rhythms.PER1 phosphorylation specifies feeding rhythm in mice.The circadian clock influences heart performance.TIMELESS mutation alters phase responsiveness and causes advanced sleep phaseHigh-throughput discovery of genetic determinants of circadian misalignmentLoss-of-function mutations with circadian rhythm regulator Per1/Per2 lead to premature ovarian insufficiency†
P50
Q24292897-845BD915-666B-4D9B-891D-99CDD55B8307Q24300992-8DCAD8DC-7B7A-43E2-B9BE-17C7629F077BQ24599500-F9BB98C5-DA5F-4099-AE2E-0DD5846F6D47Q24673774-F2F6C484-AB1B-45BB-AF2F-F1B59D6ECD34Q27863810-D840A2CB-F1F3-47C6-936F-25E000CBFFA6Q28511138-F8A76CD5-6FD6-4FE6-9871-36872DC20B7EQ33585833-3A8F0904-0033-425C-BAF6-3D86C1528858Q34249512-216949B4-222E-44AE-BA1F-BF19A02C168BQ35754678-34851A79-5679-4FC7-B7F5-061FFE6C9C0FQ36514895-9940D8E4-8EBC-4E66-A77E-C989CBEEDFE6Q37276766-F94E8C58-42FD-458D-A80E-178C91C9D358Q37294292-07DA5CF5-DC47-47BC-B15C-7834F53250D0Q37299661-7F9F7A57-4F47-4709-A752-E6E5A272C7DAQ37568176-FF085277-1A93-459F-978C-69AFA5273634Q37879671-3F00CC21-472B-4EA4-A7A7-1712235350FCQ41089484-67F8BB98-FAB9-487E-884E-DC060894678AQ45116939-FCACE9D9-F35A-4456-B03A-532D87FED2D1Q47413214-A473436C-22BF-4EBD-92D1-AD7642FBFBBCQ48104745-7C74B801-419E-47E7-BC14-7A9FCA504813Q54560082-915383B3-5E53-4BAC-B1DE-C54E7404BABEQ92355382-E287BBF5-E0B3-406A-8435-A8B691F5061AQ92589720-F716CF38-B4F3-4B8D-8726-E25AF9D6EAECQ93211282-C543C85D-17D2-49B8-81EC-07CFD80BDDA4
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Ying Xu
@ast
Ying Xu
@en
Ying Xu
@es
Ying Xu
@nl
Ying Xu
@sl
type
label
Ying Xu
@ast
Ying Xu
@en
Ying Xu
@es
Ying Xu
@nl
Ying Xu
@sl
prefLabel
Ying Xu
@ast
Ying Xu
@en
Ying Xu
@es
Ying Xu
@nl
Ying Xu
@sl
P1053
A-3009-2013
P106
P2038
P21
P31
P3829
P496
0000-0002-6689-7768
P569
2000-01-01T00:00:00Z